Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice

Neuroscience Letters

Volumn 462, Issue 1, 2009, Pages 68-72

  Waxman, Amanda R ^a   Arout, Caroline ^a   Caldwell, Megan ^c   Dahan, Albert ^b   Kest, Benjamin ^a,c  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Fentanyl; Hyperalgesia; Metabolites; NMDA; Opioid receptors

Indexed keywords

DELTA OPIATE RECEPTOR; DIZOCILPINE; FENTANYL; GLUCURONIDE; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALTREXONE; OPIATE RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG GLUCURONIDATION; DRUG TRANSFORMATION; HYPERALGESIA; LATENT PERIOD; MOUSE; NERVE CELL EXCITABILITY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; TIME;

ANALYSIS OF VARIANCE; ANIMALS; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; FENTANYL; HOT TEMPERATURE; HYPERALGESIA; MALE; MICE; MICE, KNOCKOUT; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; PAIN; PAIN MEASUREMENT; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; TIME FACTORS;

EID: 67650467328     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.06.061     Document Type: Article

References (43)

1. Armstrong S.C., and Cozza K.L. Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: theory and clinical reality. Part I. Psychosomatics 44 (2003) 167-171
2. Arner S., Rawal N., and Gustafsson L.L. Clinical experience of long-term treatment with epidural and intrathecal opioids: a nationwide survey. Acta Anaesthesiol. Scand. 32 (1988) 253-259
3. A receptor complex. Life Sci. 54 (1994) 687-694
4. Bartlett S.E., Dodd P.R., and Smith M.T. Pharmacology of morphine and morphine-3-glucuronide at opioid, excitatory amino acid, GABA and glycine binding sites. Pharmacol. Toxicol. 75 (1994) 73-81
5. Celerier E., Gonzalez J.R., Maldonado R., Cabanero D., and Puig M.M. Opioid-induced hyperalgesia in a murine model of postoperative pain: role of nitric oxide generated from inducible nitric oxide synthase. Anesthesiology 104 (2006) 546-555
6. Celerier E., Rivat C., Jun Y., Laulin J.P., Larcher A., Reynier P., and Simonnet G. Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 92 (2000) 465-472
7. Chen Z.R., Irvine R.J., Somogyi A.A., and Bochner F. Mu receptor binding of some commonly used opioids and their metabolites. Life Sci. 48 (1991) 2165-2171
8. Christrup L.L. Morphine metabolites. Acta Anaesthesiol. Scand. 41 (1997) 116-122
9. Clarke S., Czyzyk T., Ansonoff M., Nitsche J.F., Hsu M.S., Nilsson L., Larsson K., Borsodi A., Toth G., Hill R., Kitchen I., and Pintar J.E. Autoradiography of opioid and ORL1 ligands in opioid receptor triple knockout mice. Eur. J. Neurosci. 16 (2002) 1705-1712
10. Cox V., Clarke S., Czyzyk T., Ansonoff M., Nitsche J., Hsu M.S., Borsodi A., Tomboly C., Toth G., Hill R., Pintar J., and Kitchen I. Autoradiography in opioid triple knockout mice reveals opioid and opioid receptor like binding of naloxone benzoylhydrazone. Neuropharmacology 48 (2005) 228-235
11. D'Amour F.E., and Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72 (1941) 74-79
12. De Conno F., Caraceni A., Martini C., Spoldi E., Salvetti M., and Ventafridda V. Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine. Pain 47 (1991) 337-339
13. Feierman D.E., and Lasker J.M. Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4. Drug Metab. Dispos. 24 (1996) 932-939
14. Gardell L.R., King T., Ossipov M.H., Rice K.C., Lai J., Vanderah T.W., and Porreca F. Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery. Neurosci. Lett. 396 (2006) 44-49
15. Juni A., Klein G., and Kest B. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems. Brain Res. 1070 (2006) 35-44
16. Juni A., Klein G., Pintar J.E., and Kest B. Nociception increases during opioid infusion in opioid receptor triple knock-out mice. Neuroscience 147 (2007) 439-444
17. Juni A., Klein G., Kowalcyzk B., Ragnauth A., and Kest B. Sex differences in hyperalgesia during morphine infusion: effect of gonadectomy and estrogen treatment. Neuropharmacology 54 (2008) 1264-1270
18. Kest B., Hopkins E., Palmese C.A., Adler M., and Mogil J.S. Genetic variation in morphine analgesic tolerance: a survey of 11 inbred mouse strains. Pharmacol. Biochem. Behav. 73 (2002) 821-828
19. Kest B., Palmese C., and Hopkins E. A comparison of morphine analgesic tolerance in male and female mice. Brain Res. 879 (2000) 17-22
20. Kozela E., Danysz W., and Popik P. Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats. Eur. J. Pharmacol. 423 (2001) 17-26
21. Kuo C.K., Hanioka N., Hoshikawa Y., Oguri K., and Yoshimura H.J. Species difference of site-selective glucuronidation of morphine. J. Pharmacobiodyn. 14 (1991) 187-193
22. Labella F.S., Pinsky C., and Havlicek V. Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity. Brain Res. 174 (1979) 263-271
23. Laulin J.P., Maurette P., Corcuff J.B., Rivat C., Chauvin M., and Simonnet G. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth. Analg. 94 (2002) 1263-1269
24. Lipkowski A.W., Carr D.B., Langlade A., Osgood P.F., and Szyfelbein S.K. Morphine-3-glucuronide: silent regulator of morphine actions. Life Sci. 55 (1994) 149-154
25. Liu H., Mantyh P.W., and Basbaum A.I. NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature 386 (1997) 721-724
26. Liu H., Wang H., Sheng M., Jan L.Y., and Basbaum A.I. Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn. Proc. Natl. Acad. Sci. USA 91 (1994) 8383-8387
27. Mao J., Price D.D., and Mayer D.J. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J. Neurosci. 14 (1994) 2301-2312
28. Mao J., Sung B., Ji R.R., and Lim G. Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity. J. Neurosci. 22 (2002) 8312-8323
29. Mather L.E. Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin. Pharmacokinet. 8 (1983) 422-446
30. Nemmani K.V., Grisel J.E., Stowe J.R., Smith-Carliss R., and Mogil J.S. Modulation of morphine analgesia by site-specific N-methyl-d-aspartate receptor antagonists: dependence on sex, site of antagonism, morphine dose, and time. Pain 109 (2004) 274-283
31. Ossipov M.H., Lai J., King T., Vanderah T.W., Malan Jr. T.P., Hruby V.J., and Porreca F. Antinociceptive and nociceptive actions of opioids. J. Neurobiol. 61 (2004) 126-148
32. Peng P.W., and Sandler A.N. A review of the use of fentanyl analgesia in the management of acute pain in adults. Anesthesiology 90 (1999) 576-599
33. Richebe P., Rivat C., Laulin J.P., Maurette P., and Simonnet G. Ketamine improves the management of exaggerated postoperative pain observed in perioperative fentanyl-treated rats. Anesthesiology 102 (2005) 421-428
34. Rivat C., Laulin J.P., Corcuff J.B., Celerier E., Pain L., and Simonnet G. Fentanyl enhancement of carrageenan-induced long-lasting hyperalgesia in rats: prevention by the N-methyl-d-aspartate receptor antagonist ketamine. Anesthesiology 96 (2002) 381-391
35. Smith M.T. Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites. Clin. Exp. Pharmacol. Physiol. 27 (2000) 524-528
36. van Dorp E.L.A., Kest B., Kowalczyk W.J., Morariu A.M., Waxman A.R., Arout C.A., Dahan A., and Sarton E.Y. Morphine-6-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans. Anesthesiology 110 (2009) 1356-1363
37. Vanderah T.W., Suenaga N.M., Ossipov M.H., Malan Jr. T.P., Lai J., and Porreca F. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J. Neurosci. 21 (2001) 279-286
38. Wahlstrom A., Hammar L., Lundin L.G., and Rane A. Morphine metabolism in mouse brain. NIDA Res. Monogr. 75 (1986) 603-606
39. Woolf C.J. Intrathecal high dose morphine produces hyperalgesia in the rat. Brain Res. 209 (1981) 491-495
40. Xie J.Y., Herman D.S., Stiller C.-O., Gardell L.R., Ossipov M.H., Lai J., Porreca F., and Vanderah T.W. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. J. Neurosci. 25 (2005) 409-416
41. Yaksh T.L., Harty G.J., and Onofrio B.M. High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications. Anesthesiology 64 (1986) 590-597
42. Yoburn B.C., Cohen A.H., and Inturrisi C.E. Pharmacokinetics and pharmacodynamics of subcutaneous naltrexone pellets in the rat. J. Pharmacol. Exp. Ther. 237 (1986) 126-130
43. Yoshimura H., Ida S., Oguri K., and Tsukamoto H. Biochemical basis for analgesic activity of morphine-6-glucuronide. I. Penetration of morphine-6-glucuronide in the brain of rats. Biochem. Pharmacol. 22 (1973) 1423-1430